Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MPTMEDICAL PROPERTIES TRUST INC

NYSE · CIK 0001287865
Filer categoryLarge accelerated filer
Entity typeoperating
SIC6798 Real Estate Investment Trusts
FY end1231
XBRL facts487

Identity from submissions API

NameMEDICAL PROPERTIES TRUST INC
CIK0001287865
TickersMPT
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC6798 Real Estate Investment Trusts
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone205-969-3755
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
10500 LIBERTY PARKWAY
BIRMINGHAM
AL
AL
Mailing address
10500 LIBERTY PARKWAY
BIRMINGHAM
AL
AL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1388 filing rows loaded from submissions recent; extra archives: CIK0001287865-submissions-001.json (386 filings, 2004-04-16 to 2010-08-04).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468751 4502
2026-11-06 10-Q 10-Q 0001193125-26-451995 001-32559 261532788 34 15598522 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001193125-26-437067 001-32559 261497675 34 7896604 1 1
2026-10-07 4 4 0001193125-26-417145 4673
2026-10-07 4 4 0001193125-26-417144 4730
2026-10-07 4 4 0001193125-26-417143 4666
2026-10-07 4 4 0001193125-26-417142 4673
2026-10-07 4 4 0001193125-26-417141 4760
2026-10-07 4 4 0001193125-26-417140 4670
2026-08-20 4 4 0001193125-26-359423 4415
2026-08-10 8-K 8-K 1.01,2.03,9.01 0001193125-26-342713 001-32559 261259622 34 1522493 1 1
2026-08-10 10-Q 10-Q 0001193125-26-342583 001-32559 261259247 34 15281298 1 1
2026-08-10 8-K 8-K 2.02,7.01,9.01 0001193125-26-341434 001-32559 261256765 34 18198634 1 1
2026-08-06 S-8 S-8 0001193125-26-338248 333-298063 261249728 33 202464 1 1
2026-07-08 4 4 0001193125-26-298833 4670
2026-07-08 4 4 0001193125-26-298830 4666
2026-07-08 4 4 0001193125-26-298832 4673
2026-07-08 4 4 0001193125-26-298829 4730
2026-07-08 4 4 0001193125-26-298831 4673
2026-07-08 4 4 0001193125-26-298828 4760
2026-06-01 8-K 8-K 5.07,9.01 0001193125-26-251659 001-32559 261052016 34 213423 1 1
2026-05-08 10-Q 10-Q 0001193125-26-214700 001-32559 26958681 34 12622311 1 1
2026-04-30 8-K 8-K 2.02,9.01 0001193125-26-194165 001-32559 26920261 34 6552237 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000490 005-80883 26914010 34 7296
2026-04-13 ARS ARS 0001193125-26-152976 001-32559 26858235 34 17736478
2026-04-13 DEFA14A DEFA14A 0001193125-26-152974 001-32559 26858220 34 3752241
2026-04-13 DEF 14A DEF 14A 0001193125-26-152971 001-32559 26858207 34 36891142 1 1
2026-04-08 4 4 0001193125-26-148528 4672
2026-04-08 4 4 0001193125-26-148527 4729
2026-04-08 4 4 0001193125-26-148526 4665
2026-04-08 4 4 0001193125-26-148525 4669
2026-04-08 4 4 0001193125-26-148524 4759
2026-04-08 4 4 0001193125-26-148523 4672
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001740 005-80883 26802024 34 7114
2026-03-19 4 4 0001969905-26-000004 6611
2026-03-19 4 4 0001969950-26-000004 6517
2026-03-19 4 4 0001225492-26-000004 6521
2026-03-19 4 4 0001665881-26-000004 6524
2026-02-26 10-K 10-K 0001193125-26-073587 001-32559 26681848 34 62708692 1 1
2026-02-19 8-K 8-K 2.02,9.01 0001193125-26-058167 001-32559 26651610 34 5891157 1 1
2026-01-20 8-K 8-K 7.01,8.01,9.01 0001193125-26-016037 001-32559 26541254 34 179797 1 1
2026-01-09 4 4 0001193125-26-009190 4504
2026-01-09 4 4 0001193125-26-009188 4544
2026-01-09 4 4 0001193125-26-009186 4553
2026-01-09 4 4 0001193125-26-009187 6188
2026-01-09 4 4 0001193125-26-009183 4544
2026-01-09 4 4 0001193125-26-009185 4546
2026-01-09 4 4 0001193125-26-009182 4504
2026-01-09 4 4 0001193125-26-009144 4663
2026-01-09 4 4 0001193125-26-009143 4741
2026-01-09 4 4 0001193125-26-009142 4648
2026-01-09 4 4 0001193125-26-009140 4666
2026-01-09 4 4 0001193125-26-009137 8718
2026-01-09 4 4 0001193125-26-009135 8663
2026-01-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001337074-26-000002 005-80883 26510797 34 5864
2025-12-16 4 4 0001193125-25-321276 4386
2025-11-21 4 4 0001193125-25-291650 4830
2025-11-20 4 4 0001193125-25-290062 4658
2025-11-19 144 xsl144X01/primary_doc.xml 0001949846-25-000606 001-32559 251497151 33 4310
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000614 005-80883 251464581 34 8277
2025-11-07 10-Q 10-Q 0001193125-25-272324 001-32559 251462690 34 15830333 1 1
2025-10-30 8-K 8-K 2.02,8.01,9.01 0001193125-25-257549 001-32559 251432393 34 6987882 1 1
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002610 005-80883 251401823 34 11167
2025-10-07 4 4 0001193125-25-233765 4666
2025-10-07 4 4 0001193125-25-233764 4648
2025-10-07 4 4 0001193125-25-233763 4667
2025-10-07 4 4 0001193125-25-233762 4645
2025-10-07 4 4 0001193125-25-233761 4724
2025-10-07 4 4 0001193125-25-233760 4664
2025-09-26 4 4 0001193125-25-220833 7434
2025-09-26 4 4 0001193125-25-220831 7453
2025-09-26 4 4 0001193125-25-220829 7437
2025-09-26 4 4 0001193125-25-220827 7456
2025-08-14 8-K 8-K 8.01,9.01 0001193125-25-180805 001-32559 251219651 34 977357 1 1
2025-08-11 424B5 424B5 0001193125-25-178104 333-287726 251203175 33 861058 1 1
2025-08-11 8-K 8-K 8.01,9.01 0001193125-25-178048 001-32559 251202849 34 413273 1 1
2025-08-08 10-Q 10-Q 0000950170-25-106022 001-32559 251199522 34 14737628 1 1
2025-07-31 8-K 8-K 2.02,9.01 0001193125-25-170123 001-32559 251169581 34 7066811 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000957 005-80883 251160260 34 6244
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003089 005-80883 251132281 34 11031
2025-07-08 4 4 0000950170-25-094668 4663
2025-07-08 4 4 0000950170-25-094667 4648
2025-07-08 4 4 0000950170-25-094666 4644
2025-07-08 4 4 0000950170-25-094665 4667
2025-07-08 4 4 0000950170-25-094664 4597
2025-07-08 4 4 0000950170-25-094663 4667
2025-06-03 8-K 8-K 5.07,9.01 0001193125-25-134173 001-32559 251020573 34 156263 1 1
2025-06-02 S-3ASR S-3ASR 0001193125-25-133440 333-287726 251016096 33 1041857 1 1
2025-05-20 DEFA14A DEFA14A 0001193125-25-122795 001-32559 25966108 34 4080485
2025-05-09 10-Q 10-Q 0000950170-25-068203 001-32559 25931511 34 12272891 1 1
2025-05-05 4 4 0000950170-25-063782 4828
2025-05-05 144 xsl144X01/primary_doc.xml 0001949846-25-000173 001-32559 25911583 33 6396
2025-05-01 8-K 8-K 2.02,9.01 0001193125-25-109039 001-32559 25899750 34 5857915 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000513 005-80883 25892064 34 6243
2025-04-17 4 4 0000950170-25-055635 4916
2025-04-17 4 4 0000950170-25-055634 4919
2025-04-17 4 4 0000950170-25-055633 4935
2025-04-17 4 4 0000950170-25-055632 4938
2025-04-17 4 4 0000950170-25-055631 10336
2025-04-17 4 4 0000950170-25-055630 10406
2025-04-17 DEF 14A DEF 14A 0000950170-25-055431 001-32559 25847742 34 58565122 1 1
2025-04-17 ARS ARS 0000950170-25-055426 001-32559 25847707 34 38236423
2025-04-17 DEFA14A DEFA14A 0000950170-25-055421 001-32559 25847695 34 4476072
2025-04-14 4 4 0000950170-25-053880 6167
2025-04-14 4 4 0000950170-25-053826 4482
2025-04-14 4 4 0000950170-25-053824 4523
2025-04-14 4 4 0000950170-25-053823 4525
2025-04-14 4 4 0000950170-25-053822 4523
2025-04-14 4 4 0000950170-25-053821 4531
2025-04-14 4 4 0000950170-25-053818 4482
2025-04-03 4 4 0000950170-25-050802 4662
2025-04-03 4 4 0000950170-25-050801 4665
2025-04-03 4 4 0000950170-25-050800 4647
2025-04-03 4 4 0000950170-25-050799 4643
2025-04-03 4 4 0000950170-25-050798 4666
2025-04-03 4 4 0000950170-25-050797 4596
2025-03-06 4 4 0000950170-25-034778 4415
2025-03-03 10-K 10-K 0000950170-25-030989 001-32559 25699175 34 48925026 1 1
2025-02-27 8-K 8-K 2.02,9.01 0001193125-25-037671 001-32559 25673184 34 5824066 1 1
2025-02-18 8-K 8-K 1.01,2.03,9.01 0001193125-25-028746 001-32559 25636205 34 2825145 1 1
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002038212-25-000002 005-80883 25614625 34 4643
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002038212-25-000001 005-80883 25614515 34 4638
2025-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001337074-25-000001 005-80883 25598649 34 5568
2025-01-31 8-K 8-K 8.01,9.01 0001193125-25-018490 001-32559 25579555 34 219137 1 1
2025-01-29 8-K 8-K 7.01,8.01,9.01 0001193125-25-015022 001-32559 25566997 34 262383 1 1
2025-01-06 4 4 0000950170-25-002472 4651
2025-01-06 4 4 0000950170-25-002471 4654
2025-01-06 4 4 0000950170-25-002470 4672
2025-01-06 4 4 0000950170-25-002469 4603
2025-01-06 4 4 0000950170-25-002468 4669
2025-01-06 4 4 0000950170-25-002467 4673
2024-12-26 4 4 0000950170-24-140621 4801
2024-12-26 4 4 0000950170-24-140620 4394
2024-12-26 144 xsl144X01/primary_doc.xml 0001957799-24-000365 001-32559 241580961 33 4511
2024-11-13 10-Q/A 10-Q/A 0000950170-24-126476 001-32559 241455575 34 1906803 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125623 001-32559 241449597 34 14444745 1 1
2024-11-08 SC 13G/A us58463j3041_110824.txt 0002012383-24-003578 005-80883 241439732 34 13915
2024-11-07 8-K 8-K 2.02,9.01 0001193125-24-252717 001-32559 241433410 34 2746732 1 1
2024-10-24 SC 13G SC13G_MPW_2024_10 0001337074-24-000005 005-80883 241391305 34 8145
2024-10-23 SC 13G/A us58463j3041_102324.txt 0002012383-24-001852 005-80883 241389873 34 13901
2024-10-09 4 4 0000950170-24-113821 4344
2024-10-09 144 xsl144X01/primary_doc.xml 0001949846-24-000597 001-32559 241361623 33 16083
2024-10-03 4 4 0000950170-24-112456 4652
2024-10-03 4 4 0000950170-24-112455 4604
2024-10-03 4 4 0000950170-24-112454 4670
2024-10-03 4 4 0000950170-24-112453 4731
2024-10-03 4 4 0000950170-24-112452 4655
2024-10-03 4 4 0000950170-24-112451 4674
2024-09-19 4 4 0000950170-24-108220 4342
2024-09-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002038212-24-000001 005-80883 241310163 34 6133
2024-09-17 8-K 8-K 1.02,2.06,9.01 0001193125-24-220733 001-32559 241305424 34 209944 1 1
2024-08-27 4 4 0000950170-24-101158 4736
2024-08-15 4 4 0000950170-24-097720 4725
2024-08-15 144 xsl144X01/primary_doc.xml 0001949846-24-000472 001-32559 241211451 33 4236
2024-08-09 10-Q 10-Q 0000950170-24-094888 001-32559 241193939 34 14697070 1 1
2024-08-08 8-K 8-K 1.01,2.02,2.03,9.01 0001193125-24-196518 001-32559 241186248 34 8004259 1 1
2024-07-31 3 3 0000950170-24-088893 22716
2024-07-08 4 4 0000950170-24-082210 4713
2024-07-08 4 4 0000950170-24-082209 4710
2024-07-08 4 4 0000950170-24-082208 4674
2024-07-08 4 4 0000950170-24-082207 4604
2024-07-08 4 4 0000950170-24-082205 4673
2024-06-03 8-K 8-K 5.07,9.01 0001193125-24-153035 001-32559 241013804 34 166399 1 1
2024-05-29 10-Q 10-Q 0000950170-24-065929 001-32559 24998422 34 10889861 1 1
2024-05-29 8-K/A 8-K/A 2.02,9.01 0001193125-24-149138 001-32559 24998342 34 8691398 1 1
2024-05-28 8-K 8-K 2.03 0001193125-24-147330 001-32559 24986116 34 190751 1 1
2024-05-22 DEFA14A DEFA14A 0001193125-24-144503 001-32559 24971749 34 1073115
2024-05-16 8-K 8-K 3.01,7.01,9.01 0001193125-24-140662 001-32559 24956356 34 217108 1 1
2024-05-13 NT 10-Q NT 10-Q 0001193125-24-136309 001-32559 24936170 34 32554
2024-05-10 8-K 8-K 2.06 0001193125-24-136307 001-32559 24936164 34 193586 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001193125-24-134847 001-32559 24928929 34 5894297 1 1
2024-05-07 8-K 8-K 8.01 0001193125-24-133302 001-32559 24923297 34 195164 1 1
2024-04-23 4 4 0000950170-24-047146 6158
2024-04-23 4 4 0000950170-24-047149 6136
2024-04-23 4 4 0000950170-24-047147 6090
2024-04-23 4 4 0000950170-24-047148 6160
2024-04-23 4 4 0000950170-24-047145 6139
2024-04-18 8-K 8-K 1.01,1.02,2.01,7.01,9.01 0001193125-24-100968 001-32559 24855140 34 395517 1 1
2024-04-17 ARS ARS 0001193125-24-099234 001-32559 24851887 34 2015786
2024-04-17 DEFA14A DEFA14A 0001193125-24-099229 001-32559 24851868 34 900642
2024-04-17 DEF 14A DEF 14A 0001193125-24-099222 001-32559 24851839 34 13325902 1 1
2024-04-01 4 4 0000950170-24-039722 6436
2024-04-01 4 4 0000950170-24-039721 6439
2024-04-01 4 4 0000950170-24-039720 6458
2024-04-01 4 4 0000950170-24-039719 6633
2024-04-01 4 4 0000950170-24-039718 6704
2024-03-15 4 4 0000950170-24-032377 4555
2024-03-15 4 4 0000950170-24-032375 4551
2024-03-15 4 4 0000950170-24-032376 4513
2024-03-15 4 4 0000950170-24-032373 4554
2024-03-15 4 4 0000950170-24-032371 6198
2024-03-15 4 4 0000950170-24-032370 4562
2024-03-15 4 4 0000950170-24-032374 4513
2024-03-14 4/A 4/A 0000950170-24-031824 6881
2024-03-14 4/A 4/A 0000950170-24-031823 6809
2024-03-14 8-K 8-K 5.02,9.01 0001193125-24-068020 001-32559 24751202 34 182519 1 1
2024-03-12 4 4 0000950170-24-030346 8354
2024-03-12 4 4 0000950170-24-030343 8426
2024-02-29 10-K 10-K 0000950170-24-023248 001-32559 24704978 34 42588939 1 1
2024-02-29 UPLOAD filename1.pdf 0000000000-24-002271 001-32559 42042
2024-02-21 8-K 8-K 2.02,9.01 0001193125-24-040842 001-32559 24656527 34 3035069 1 1
2024-02-14 5 5 0000950170-24-015426 6100
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021445 005-80883 24628958 34 13089
2024-02-08 CORRESP filename1.htm 0001193125-24-028390 20934
2024-01-30 SC 13G/A Medical_Proprt_Trust.txt 0000093751-24-000371 005-80883 24576508 34 8665
2024-01-25 UPLOAD filename1.pdf 0000000000-24-001004 001-32559 42113
2024-01-25 UPLOAD filename1.pdf 0000000000-24-001000 001-32559 85198
2024-01-24 CORRESP filename1.htm 0001193125-24-014164 21064
2024-01-23 SC 13G/A us58463j3041_012324.txt 0001086364-24-001721 005-80883 24552734 34 13798
2024-01-09 UPLOAD filename1.pdf 0000000000-24-000318 001-32559 43661
2024-01-08 4 4 0000950170-24-003095 4656
2024-01-08 4 4 0000950170-24-003094 4653
2024-01-08 4 4 0000950170-24-003093 4675
2024-01-08 4 4 0000950170-24-003092 4604
2024-01-08 4 4 0000950170-24-003090 4674
2024-01-05 8-K 8-K 1.01,7.01,9.01 0001193125-24-002655 001-32559 24514054 34 234930 1 1
2023-12-14 8-K 8-K 5.02,9.01 0001193125-23-295523 001-32559 231487492 34 180998 1 1
2023-12-12 4 4 0000950170-23-069827 5686
2023-12-12 4 4 0000950170-23-069826 5689
2023-12-12 4 4 0000950170-23-069825 5708
2023-11-21 CORRESP filename1.htm 0001193125-23-281372 20535
2023-11-09 10-Q 10-Q 0000950170-23-062169 001-32559 231393302 34 15939763 1 1
2023-11-07 UPLOAD filename1.pdf 0000000000-23-012208 001-32559 45640
2023-10-26 8-K 8-K 2.02,9.01 0001193125-23-263599 001-32559 231347643 34 7136154 1 1
2023-10-12 4 4 0000950170-23-053142 4425
2023-10-12 4 4 0000950170-23-053141 4439
2023-10-12 4 4 0000950170-23-053140 4444
2023-10-12 4 4 0000950170-23-053139 4580
2023-10-12 4 4 0000950170-23-053138 4417
2023-09-13 4 4 0000950170-23-047960 6522
2023-09-13 4 4 0000950170-23-047961 6503
2023-09-13 4 4 0000950170-23-047959 6517
2023-08-09 10-Q 10-Q 0000950170-23-040734 001-32559 231156232 34 17038334 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001193125-23-205633 001-32559 231149487 34 9306003 1 1
2023-07-18 CORRESP filename1.htm 0001193125-23-188870 83920
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000044 4728
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000043 4715
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000042 8199
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000041 8205
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000040 8136
2023-07-10 4 PRIMARY DOCUMENT 0001287865-23-000039 8212
2023-07-03 UPLOAD filename1.pdf 0000000000-23-007042 001-32559 54675
2023-06-02 4 PRIMARY DOCUMENT 0001287865-23-000037 7878
2023-06-02 4 PRIMARY DOCUMENT 0001287865-23-000036 7832
2023-05-30 4 PRIMARY DOCUMENT 0001287865-23-000035 8032
2023-05-26 8-K 8-K 5.07,9.01 0001193125-23-155432 001-32559 23968836 34 165735 1 1
2023-05-25 8-K 8-K 8.01,9.01 0001193125-23-153419 001-32559 23955910 34 221864 1 1
2023-05-10 10-Q 10-Q 0000950170-23-020652 001-32559 23907536 34 13874239 1 1
2023-04-27 ARS ARS 0001193125-23-122527 001-32559 23858307 34 19405037
2023-04-27 DEFA14A DEFA14A 0001193125-23-122509 001-32559 23858196 34 359242
2023-04-27 DEF 14A DEF 14A 0001193125-23-122489 001-32559 23858122 34 14074529 1 1
2023-04-27 8-K 8-K 2.02,9.01 0001193125-23-120216 001-32559 23852087 34 6429645 1 1
2023-04-14 4 PRIMARY DOCUMENT 0001287865-23-000034 4727
2023-04-14 4 PRIMARY DOCUMENT 0001287865-23-000033 4713
2023-04-14 4 PRIMARY DOCUMENT 0001287865-23-000032 4697
2023-04-14 4 PRIMARY DOCUMENT 0001287865-23-000031 4730
2023-04-14 3/A PRIMARY DOCUMENT 0001287865-23-000029 4131
2023-04-14 3/A PRIMARY DOCUMENT 0001287865-23-000028 4043
2023-04-14 4/A PRIMARY DOCUMENT 0001287865-23-000027 4959
2023-04-14 4/A PRIMARY DOCUMENT 0001287865-23-000026 4993
2023-04-14 4/A PRIMARY DOCUMENT 0001287865-23-000025 4924
2023-04-14 4/A PRIMARY DOCUMENT 0001287865-23-000024 4994
2023-04-10 8-K 8-K 7.01,9.01 0001193125-23-095514 001-32559 23809507 34 178089 1 1
2023-03-31 8-K 8-K 7.01,9.01 0001193125-23-086105 001-32559 23782842 34 192449 1 1
2023-03-24 CORRESP filename1.htm 0001193125-23-079218 33080
2023-03-20 3 PRIMARY DOCUMENT 0001287865-23-000023 3520
2023-03-20 3 PRIMARY DOCUMENT 0001287865-23-000022 3534
2023-03-15 4 PRIMARY DOCUMENT 0001287865-23-000021 6164
2023-03-01 10-K 10-K 0000950170-23-005575 001-32559 23694227 34 55145038 1 1
2023-02-27 8-K FORM 8-K 7.01,9.01 0001193125-23-049940 001-32559 23670338 34 2984305 1 1
2023-02-23 8-K 8-K 5.02,7.01,9.01 0001193125-23-046802 001-32559 23661030 34 165115 1 1
2023-02-23 8-K 8-K 2.02,9.01 0001193125-23-045747 001-32559 23656513 34 8685183 1 1
2023-02-13 5 PRIMARY DOCUMENT 0001287865-23-000020 4778
2023-02-13 5 PRIMARY DOCUMENT 0001287865-23-000019 4817
2023-02-13 5 PRIMARY DOCUMENT 0001287865-23-000018 4748
2023-02-13 5 PRIMARY DOCUMENT 0001287865-23-000017 4817
2023-02-13 5 PRIMARY DOCUMENT 0001287865-23-000016 18393
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016454 005-80883 23603715 34 12979
2023-02-08 CORRESP filename1.htm 0001193125-23-028578 41050
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000015 4584
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000014 4576
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000013 4577
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000012 4573
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000011 4535
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000010 4535
2023-02-07 4 PRIMARY DOCUMENT 0001287865-23-000009 4732
2023-02-03 SC 13G/A Medical_Properties_Trust_Inc.txt 0000093751-23-000147 005-80883 23584810 34 8718
2023-01-26 SC 13G/A us58463j3041_012623.txt 0001306550-23-004012 005-80883 23554302 34 13575
2023-01-25 4 PRIMARY DOCUMENT 0001287865-23-000008 8219
2023-01-25 4 PRIMARY DOCUMENT 0001287865-23-000007 12352
2023-01-25 4 PRIMARY DOCUMENT 0001287865-23-000006 12284
2023-01-25 4 PRIMARY DOCUMENT 0001287865-23-000005 12355
2023-01-25 UPLOAD filename1.pdf 0000000000-23-000816 001-32559 47856
2023-01-20 SC 13G us58463j3041_012023.txt 0001306550-23-001496 005-80883 23541837 34 13538
2023-01-12 4 PRIMARY DOCUMENT 0001287865-23-000004 4699
2023-01-12 4 PRIMARY DOCUMENT 0001287865-23-000003 4629
2023-01-12 4 PRIMARY DOCUMENT 0001287865-23-000002 4699
2023-01-12 4 PRIMARY DOCUMENT 0001287865-23-000001 4660
2022-11-09 10-Q 10-Q 0000950170-22-023957 001-32559 221373367 34 14857569 1 1
2022-11-02 CORRESP filename1.htm 0001193125-22-275863 65899
2022-10-27 8-K 8-K 2.02,9.01 0001193125-22-270499 001-32559 221335157 34 6233502 1 1
2022-10-19 UPLOAD filename1.pdf 0000000000-22-011472 001-32559 50522
2022-10-11 8-K 8-K 8.01,9.01 0001193125-22-260655 001-32559 221304340 34 168635 1 1
2022-10-04 4 PRIMARY DOCUMENT 0001287865-22-000028 4659
2022-10-04 4 PRIMARY DOCUMENT 0001287865-22-000027 4698
2022-10-04 4 PRIMARY DOCUMENT 0001287865-22-000026 4630
2022-10-04 4 PRIMARY DOCUMENT 0001287865-22-000025 4699
2022-09-28 CORRESP filename1.htm 0001193125-22-253237 30999
2022-09-14 UPLOAD filename1.pdf 0000000000-22-010063 001-32559 49992
2022-08-09 10-Q 10-Q 0000950170-22-016126 001-32559 221149026 34 13490297 1 1
2022-08-08 S-8 S-8 0000950170-22-015587 333-266653 221145078 33 314784
2022-08-03 8-K 8-K 2.02,7.01,9.01 0001193125-22-210654 001-32559 221131054 34 12203578 1 1
2022-07-06 8-K 8-K 1.01,2.03,9.01 0001193125-22-188575 001-32559 221068761 34 1206092 1 1
2022-07-05 4 PRIMARY DOCUMENT 0001287865-22-000024 4668
2022-07-05 4 PRIMARY DOCUMENT 0001287865-22-000023 4698
2022-07-05 4 PRIMARY DOCUMENT 0001287865-22-000022 4698
2022-07-05 4 PRIMARY DOCUMENT 0001287865-22-000021 4629
2022-05-27 8-K 8-K 5.07,9.01 0000950170-22-010865 001-32559 22978137 34 237695 1 1
2022-05-10 10-Q 10-Q 0000950170-22-009064 001-32559 22910989 34 10958772 1 1
2022-04-28 DEFA14A DEFA14A 0001193125-22-127531 001-32559 22866499 34 326551
2022-04-28 DEF 14A DEF 14A 0001193125-22-127504 001-32559 22866385 34 7811223
2022-04-28 8-K 8-K 2.02,7.01,9.01 0001193125-22-125651 001-32559 22862597 34 13932715 1 1
2022-04-08 4 PRIMARY DOCUMENT 0001287865-22-000020 4869
2022-04-01 4 PRIMARY DOCUMENT 0001287865-22-000019 6700
2022-04-01 4 PRIMARY DOCUMENT 0001287865-22-000018 4936
2022-03-18 8-K FORM 8-K 7.01,9.01 0001193125-22-079576 001-32559 22753143 34 181118 1 1
2022-03-17 4 PRIMARY DOCUMENT 0001287865-22-000017 4532
2022-03-10 4 PRIMARY DOCUMENT 0001287865-22-000016 4369
2022-03-02 3 PRIMARY DOCUMENT 0001287865-22-000015 2780
2022-03-01 10-K 10-K 0001564590-22-008100 001-32559 22699576 34 51458963 1 1
2022-02-23 8-K 8-K 5.02,7.01,9.01 0001193125-22-050231 001-32559 22665069 34 168608 1 1
2022-02-14 SC 13G/A mpw13gbody-123121.htm 0001284812-22-000111 005-80883 22626459 34 130299
2022-02-11 5 PRIMARY DOCUMENT 0001287865-22-000014 4487
2022-02-11 SC 13G MEDICAL_PROPERTIES_TRUST_INC.txt 0000093751-22-000299 005-80883 22619479 34 8663
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018072 005-80883 22610418 34 12974
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000013 4582
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000012 4574
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000011 4575
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000010 4571
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000009 4533
2022-02-04 4 PRIMARY DOCUMENT 0001287865-22-000008 4729
2022-02-04 SC 13G/A SEC SCHEDULE 13G 0001678858-22-000181 005-80883 22591326 34 33508
2022-02-03 8-K 8-K 2.02,9.01 0001193125-22-026488 001-32559 22586679 34 4826457 1 1
2022-02-02 4 PRIMARY DOCUMENT 0001287865-22-000007 6857
2022-01-31 4 PRIMARY DOCUMENT 0001287865-22-000006 6790
2022-01-31 4 PRIMARY DOCUMENT 0001287865-22-000005 6858
2022-01-28 SC 13G/A us58463j3041_012822.txt 0000834237-22-003312 005-80883 22567558 34 13609
2022-01-19 4 PRIMARY DOCUMENT 0001287865-22-000004 8303
2022-01-19 4 PRIMARY DOCUMENT 0001287865-22-000003 8678
2022-01-19 4 PRIMARY DOCUMENT 0001287865-22-000002 8608
2022-01-19 4 PRIMARY DOCUMENT 0001287865-22-000001 8678
2022-01-03 S-3ASR S-3ASR 0001193125-21-370837 333-261966 211534201 33 824273
2021-11-09 10-Q 10-Q 0001564590-21-055782 001-32559 211392874 34 14138716 1 1
2021-10-28 8-K 8-K 2.02,9.01 0001193125-21-310471 001-32559 211355207 34 5125488 1 1
2021-10-13 8-K 8-K 1.01,9.01 0001193125-21-297933 001-32559 211321853 34 1055427 1 1
2021-09-28 8-K 8-K 8.01,9.01 0001193125-21-284602 001-32559 211283419 34 558596 1 1
2021-09-24 424B2 424(B)(2) 0001193125-21-282386 333-229103 211277650 33 2037121
2021-09-22 FWP FWP 0001193125-21-279464 333-229103 211269915 34 27322
2021-09-22 424B5 424B5 0001193125-21-278803 333-229103 211268111 33 2025832
2021-09-01 8-K 8-K 7.01,9.01 0001193125-21-263302 001-32559 211230509 34 273690 1 1
2021-08-09 10-Q 10-Q 0001564590-21-042697 001-32559 211157084 34 11156804 1 1
2021-08-03 4 PRIMARY DOCUMENT 0001287865-21-000019 4368
2021-07-29 8-K 8-K 2.02,9.01 0001193125-21-228292 001-32559 211125144 34 6398816 1 1
2021-07-01 4 PRIMARY DOCUMENT 0001287865-21-000018 6662
2021-06-09 8-K 8-K 7.01,9.01 0001193125-21-186118 001-32559 211004113 34 8385729 1 1
2021-06-09 10-K/A 10-K/A 0001564590-21-032186 001-32559 211004103 34 1714365 1 1
2021-05-28 8-K 8-K 5.07,9.01 0001193125-21-177089 001-32559 21980916 34 168808 1 1
2021-05-10 10-Q 10-Q 0001564590-21-026134 001-32559 21908569 34 10575871 1 1
2021-04-29 8-K 8-K 2.02,9.01 0001193125-21-138537 001-32559 21867378 34 5352945 1 1
2021-04-26 DEFA14A DEFA14A 0001193125-21-131581 001-32559 21854304 34 255495
2021-04-26 DEF 14A DEF 14A 0001193125-21-131567 001-32559 21854242 34 8074633
2021-03-31 4 PRIMARY DOCUMENT 0001287865-21-000017 4936
2021-03-29 8-K FORM 8-K 1.01,9.01 0001193125-21-098399 001-32559 21782230 34 1920972 1 1
2021-03-22 8-K FORM 8-K 8.01,9.01 0001193125-21-089726 001-32559 21762029 34 579407 1 1
2021-03-19 424B2 424B2 0001193125-21-087664 333-229103 21758919 33 1992144
2021-03-18 4 PRIMARY DOCUMENT 0001287865-21-000016 4896
2021-03-17 FWP FWP 0001193125-21-084146 333-229103 21751088 34 36522
2021-03-17 424B5 424B5 0001193125-21-083406 333-229103 21748365 33 1979831
2021-03-01 10-K 10-K 0001564590-21-009901 001-32559 21698565 34 44484773 1 1
2021-02-25 4 PRIMARY DOCUMENT 0001287865-21-000015 4372
2021-02-16 SC 13G/A mpw13gbody-123120.txt 0001284812-21-000108 005-80883 21633351 34 17335
2021-02-12 5 PRIMARY DOCUMENT 0001287865-21-000014 5443
2021-02-12 5 PRIMARY DOCUMENT 0001287865-21-000013 4487
2021-02-12 5 PRIMARY DOCUMENT 0001287865-21-000012 4552
2021-02-12 5 PRIMARY DOCUMENT 0001287865-21-000011 9878
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018609 005-80883 21611432 34 13848
2021-02-04 SC 13G SEC SCHEDULE 13G 0000902219-21-000137 005-80883 21589289 34 33659
2021-02-04 8-K 8-K 2.02,9.01 0001193125-21-028200 001-32559 21589013 34 5270361 1 1
2021-01-27 SC 13G/A us58463j3041_012621.txt 0000834237-21-002190 005-80883 21556198 34 13590
2021-01-22 8-K 8-K 1.01,2.03 0001193125-21-014820 001-32559 21546357 34 203636 1 1
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000010 4571
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000009 4533
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000008 4575
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000007 4582
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000006 4729
2021-01-21 4 PRIMARY DOCUMENT 0001287865-21-000005 4574
2021-01-20 4 PRIMARY DOCUMENT 0001287865-21-000004 10487
2021-01-20 4 PRIMARY DOCUMENT 0001287865-21-000003 14701
2021-01-20 4 PRIMARY DOCUMENT 0001287865-21-000002 14775
2021-01-20 4 PRIMARY DOCUMENT 0001287865-21-000001 14723

Latest XBRL company facts

One latest value per concept from companyfacts (487 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 598.10M 2026-05-06 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
dei EntityPublicFloat Entity Public Float USD 2.60B 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-073587
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 5 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.60M 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.39M 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 163.81 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 16.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd PeoTotalCompAmt PeoTotalCompAmt USD 15.90M 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 37.95 2025-01-01 2025-12-31 DEF 14A 2026-04-13 0001193125-26-152971
ffd NetFeeAmt NetFeeAmt USD 7,623.12 2026-08-05 S-8 2026-08-06 0001193125-26-338248
ffd TtlFeeAmt TtlFeeAmt USD 7,623.12 2026-08-05 S-8 2026-08-06 0001193125-26-338248
ffd TtlOfferingAmt TtlOfferingAmt USD 55.20M 2026-08-05 S-8 2026-08-06 0001193125-26-338248
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-05 S-8 2026-08-06 0001193125-26-338248
srt MortgageLoansOnRealEstateCollectionsOfPrincipal SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal USD 16.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
srt MortgageLoansOnRealEstateFaceAmountOfMortgages SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages USD 159.29M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
srt MortgageLoansOnRealEstateFederalIncomeTaxBasis1 SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Federal Income Tax Basis USD 159.30M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
srt MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
srt MortgageLoansOnRealEstatePriorLiens1 SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Prior Lien, Amount USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
srt RealEstateAndAccumulatedDepreciationAmountOfEncumbrances SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances USD 850.78M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
srt RealEstateFederalIncomeTaxBasis SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis USD 12.00B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 433.17M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 20.97M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD 13.00M 2023-03-31 2023 Q3 10-Q 2023-11-09 0000950170-23-062169
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 123.70M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 6.46M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.25B 2015-03-31 2015 Q1 10-Q 2015-05-11 0001193125-15-182296
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 8.58B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Other (Deprecated 2011-01-31) USD -3.73M 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-09 0001193125-11-214626
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.95M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 727,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 9.90M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 11.00M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap AllowanceForNotesAndLoansReceivableCurrent Financing Receivable, Allowance for Credit Loss, Current USD 12.00M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 6.98M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 112,452 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 19.01M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap Assets Assets USD 14.76B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap BilledContractReceivables Billed Contracts Receivable USD 1.50M 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 9.54B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 261.10M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 0.97 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 1.14 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax, Per Share, Diluted USD/shares 0.55 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap BusinessAcquisitionProFormaRevenue Business Acquisition, Pro Forma Revenue (Deprecated 2011-01-31) USD 74.12M 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-09 0001193125-11-214626
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 621.49M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) USD 14.59M 2011-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD 89.57M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 418.81M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 839.57M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 46.27M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 1.40B 2019-08-23 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual USD 3.30M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 142.09M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities USD 245.27M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028962
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 29.32M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CapitalLeasedAssetsNumberOfUnits Capital Leased Assets, Number of Units pure 3 2011-10-31 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap CapitalLeasesFutureMinimumPaymentsReceivable Capital Leases, Future Minimum Payments Receivable USD 2.09B 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue Capital Leases, Income Statement, Direct Financing Lease Revenue USD 52.17M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 425.00M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 71.31M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 88.86M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406331
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 712.52M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028962
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 427.95M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -114.26M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.32 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.09 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 750.00M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 597.72M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 597.72M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CommonStockValue Common Stock, Value, Issued USD 598,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -11.69M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 280,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -11.41M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD -18.80M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 167.42M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap ContractRevenueCost Contract Revenue Cost (Deprecated 2018-01-31) USD 35.12M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012958
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 18.58M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ConvertibleDebt Convertible Debt USD 5.00M 2012-03-01 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 97.33M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CostsAndExpenses Costs and Expenses USD 245.19M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD -8.40M 2020-01-01 2020-03-31 2020 Q2 10-Q 2020-08-07 0001564590-20-038475
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 27.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 27.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.70M 2012-03-01 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 9.79B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.069 2011-04-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 75,000 2012-09-30 2012 Q3 10-Q 2012-11-09 0001193125-12-463187
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 35.40M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-10 0001193125-16-585681
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 6.15M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055782
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 800,000 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 127.56M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 10.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 10.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 286.68M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 287,000 2016-12-31 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap DeferredRevenue Deferred Revenue USD 15.55M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012958
us-gaap DeferredRevenueLeasesNet Deferred Lease Income, after Accumulated Amortization USD 1.83B 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap DeferredTaxAssetParentsBasisInDiscontinuedOperation Deferred Tax Asset, Parent's Basis in Discontinued Operation USD 1.20M 2010-06-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 9.50M 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 625.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 143.69M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 9.53M 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009901
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 135.88M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 334.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 78.30M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 8.60M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 99.90M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 10.26M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 70.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax USD 100,000 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6.20M 2015-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 66.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses USD 7.75M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 2.10M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 489.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 150.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 26.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 4.10M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 149.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 69.72M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 73.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DerivativeAssets Derivative Asset USD 3.00M 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030989
us-gaap DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net USD 16.00M 2023-01-01 2023-03-31 2024 FY 10-K 2025-03-03 0000950170-25-030989
us-gaap DerivativeLiabilities Derivative Liability USD 4.20M 2021-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap DerivativeNetHedgeIneffectivenessGainLoss Derivative, Net Hedge Ineffectiveness Gain (Loss) USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap DerivativeNumberOfInstrumentsHeld Derivative, Number of Instruments Held Derivative 0 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap DirectCostsOfLeasedAndRentedPropertyOrEquipment Direct Costs of Leased and Rented Property or Equipment USD 4.10M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-021127
us-gaap DirectFinancingLeaseDeferredSellingProfit Direct Financing Lease, Deferred Selling Profit USD 1.62B 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006950
us-gaap DirectFinancingLeaseLeaseReceivable Direct Financing Lease, Lease Receivable USD 564.78M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DirectFinancingLeaseNetInvestmentInLease Direct Financing Lease, Net Investment in Lease USD 250.92M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DirectFinancingLeaseRevenue Direct Financing Lease, Revenue USD 10.06M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DirectFinancingLeaseUnguaranteedResidualAsset Direct Financing Lease, Unguaranteed Residual Asset USD 203.82M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 7.66M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001193125-16-485612
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share USD/shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001193125-15-372198
us-gaap DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization Disposal Group, Including Discontinued Operation, Depreciation and Amortization USD 15.85M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss Disposal Group, Including Discontinued Operation, Gross Profit (Loss) USD 787.70M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 88.84M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 54.26M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap DividendsPayableAmount Dividends Payable, Amount (Deprecated 2012-01-31) USD 27.18M 2012-03-31 2012 Q1 10-Q 2012-05-10 0001193125-12-225832
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 54.26M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.05 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 1.05 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-009064
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.05 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.163 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.194 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.112 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD 16.92M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -2.02M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406331
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -1.78M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 52.00M 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) pure 2.4 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 900,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2022-03-14 2022 Q2 10-Q 2022-08-09 0000950170-22-016126
us-gaap EquityMethodInvestments Equity Method Investments USD 1.18B 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 5.50M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.4 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012958
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 131,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.93M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 4.78M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 4.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 133,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 138,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 137,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 135,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 134,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 31,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 2.85M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 10,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009901
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 1.63M 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030989
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.066 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 42.77M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 170.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 600.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 32.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 29.17M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 29.84M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 31.68M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 31.85M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap FiniteLivedIntangibleAssetsWeightedAverageUsefulLife Finite-Lived Intangible Assets, Weighted-Average Useful Life (Deprecated 2012-01-31) years 14.1 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 3.54M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 3.58M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 3.87M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 3.77M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 3.83M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap GainLossOnDispositionOfRealEstateDiscontinuedOperations Gain (Loss) on Disposition of Real Estate, Discontinued Operations USD -800,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 40.95M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 61.22M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 5.43M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap GainsLossesOnSalesOfInvestmentRealEstate Gains (Losses) on Sales of Investment Real Estate USD -790,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.20M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ImpairmentOfRealEstate Impairment of Real Estate USD 180.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest USD 442,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012958
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -219.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 285,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 108.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 291.24M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0.21 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001193125-17-166093
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 0.82 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 0.82 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -1,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -1,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001193125-17-166093
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 15.74M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 20.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -32.82M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD -426,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 20.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 63,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 46.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 941,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030989
us-gaap IncomeTaxReconciliationDeductionsDividends Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount USD 98.03M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -49.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 600,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-485612
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD -26.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -61.81M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 17.59M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055782
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -321,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.05M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap IncreaseDecreaseInDerivativeAssets Increase (Decrease) in Derivative Assets USD 80.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -556,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap InterestAndFeeIncomeLoansCommercialRealEstate Interest and Fee Income, Loans, Commercial, Real Estate USD 162.46M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap InterestAndOtherIncome Interest and Other Income USD 10.29M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap InterestExpense Interest Expense USD 133.33M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 174.06M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap InterestPaidCapitalized Interest Paid, Capitalized, Investing Activities USD 12.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap InvestmentCompanyDividendDistribution Investment Company, Dividend Distribution USD 11.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap InvestmentIncomeInterest Investment Income, Interest USD -16,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-10 0001193125-12-225832
us-gaap InvestmentIncomeNet Investment Income, Net USD -1.66M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 115.00M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 115.00M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap Investments Investments USD 40.31M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 75.00M 2013-06-11 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap Land Land USD 1.79B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 9.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap LeaseCost Lease, Cost USD 7.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LeaseIncentiveReceivableCurrent Lease Incentive Receivable, Current USD 2.50M 2011-06-30 2011 Q2 10-Q 2011-08-09 0001193125-11-214626
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 194.35M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 160.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 7.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.73M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.71M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 6.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 6.57M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.49M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 122.35M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 26.47B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 983.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 978.95M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 877.28M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 2.54M 2019-03-31 2019 Q1 10-Q 2019-05-10 0001564590-19-018581
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 21.67B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 990.13M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 969.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap Liabilities Liabilities USD 10.22B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 14.76B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 22.66M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001193125-15-372198
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 98.40M 2011-06-30 2011 Q2 10-Q 2011-08-09 0001193125-11-214626
us-gaap LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount USD 1.40M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap LineOfCreditFacilityIncreaseAdditionalBorrowings Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) USD 330.00M 2011-04-01 2011-04-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod Line of Credit Facility, Maximum Amount Outstanding During Period USD 450.00M 2010-05-01 2010-05-31 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 1.00B 2022-03-15 2023 Q3 10-Q 2023-11-09 0000950170-23-062169
us-gaap LineOfCreditFacilityPeriodicPayment Line of Credit Facility, Periodic Payment USD 900.00M 2014-06-18 2014-06-19 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure 0.003 2017-02-01 2017 Q3 10-Q 2017-11-09 0001193125-17-338942
us-gaap LoansAndLeasesReceivableAllowance Loans and Leases Receivable, Allowance USD 8.40M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap LoansAndLeasesReceivableOther Loans and Leases Receivable, Gross, Other (Deprecated 2016-01-31) USD 100,000 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap LoansHeldForSaleFairValueDisclosure Loans Held-for-sale, Fair Value Disclosure USD 668.22M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LoansReceivableNet Loans Receivable, Net (Deprecated 2019-01-31) USD 1.59B 2019-06-30 2019 Q2 10-Q 2019-08-09 0001564590-19-031304
us-gaap LongTermDebt Long-term Debt USD 9.66B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 8.66B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 4.83B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.60B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 471.63M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 462.94M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 900.00M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 793.62M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 1.24B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.15 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 1.05M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 280,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 524,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap MortgageLoanRelatedToPropertySales1 Mortgage Loan Related to Property Sales USD 12.50M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-01 0001193125-17-065943
us-gaap MortgageLoansOnRealEstate SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate USD 123.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap MortgageLoansOnRealEstateCarryingAmountOfMortgages Mortgage Loans on Real Estate, Carrying Amount of Mortgages (Deprecated 2018-01-31) USD 1.78B 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap MortgageLoansOnRealEstateCollectionsOfPrincipal Mortgage Loans on Real Estate, Collections of Principal USD 310.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap MortgageLoansOnRealEstateCommercialAndConsumerNet Mortgage Loans on Real Estate, Commercial and Consumer, Net USD 124.48M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap MortgageLoansOnRealEstateFaceAmountOfMortgages Mortgage Loans on Real Estate, Face Amount of Mortgages USD 1.78B 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap MortgageLoansOnRealEstateFederalIncomeTaxBasis Mortgage Loans on Real Estate, Federal Income Tax Basis (Deprecated 2013-01-31) USD 368.65M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap MortgageLoansOnRealEstateFederalIncomeTaxBasis1 Mortgage Loans on Real Estate, Federal Income Tax Basis USD 1.78B 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap MortgageLoansOnRealEstateInterestRate Mortgage Loans on Real Estate, Interest Rate pure 0.062 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap MortgageLoansOnRealEstateNewMortgageLoans SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan USD 16.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap MortgageLoansOnRealEstateOtherAdditions SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Other Addition USD 1.83B 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap MortgageLoansOnRealEstateOtherDeductions SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Other Deduction USD 17.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap MortgageLoansOnRealEstatePeriodIncreaseDecrease SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Period Increase (Decrease) USD -3.65M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans Mortgage Loans on Real Estate, Principal Amount of Delinquent Loans USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap MortgageLoansOnRealEstatePriorLiens1 Mortgage Loans on Real Estate, Prior Liens USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -23.22M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -76.78M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -14.26M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 32.83M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 280,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NetInvestmentInDirectFinancingAndSalesTypeLeases Net Investment in Direct Financing and Sales Type Leases USD 688.89M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042649
us-gaap NetInvestmentInLease Net Investment in Lease USD 381.59M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 5.10M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 1.38M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -6.59M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 31.34M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 19.34M 2013-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap NotesReceivableGross Financing Receivable, before Allowance for Credit Loss USD 602.48M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052588
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 1.54B 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 700,000 2012-06-30 2012 Q2 10-Q 2012-08-09 0001193125-12-347955
us-gaap NotionalAmountOfInterestRateDerivatives Notional Amount of Interest Rate Derivatives (Deprecated 2013-01-31) USD 65.00M 2010-06-30 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap NumberOfBusinessesAcquired Number of Businesses Acquired Hospital 2 2013-05-05 2013-06-11 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap NumberOfCountriesInWhichEntityOperates Number of Countries in which Entity Operates Country 6 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052588
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap NumberOfStatesInWhichEntityOperates Number of States in which Entity Operates State 30 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 485.58M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap OperatingLeaseCost Operating Lease, Cost USD 9.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 9.40M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009901
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 72.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.46M 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 232.98M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.60M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 6.86M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6.84M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.84M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 6.90M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 198.93M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 86.50M 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 500,000 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 4.30M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.061 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 50.13M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap OtherAssets Other Assets USD 563.82M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap OtherAssetsMiscellaneous Other Assets, Miscellaneous USD 196.90M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055782
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -44.51M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD -3.32M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 1.60M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2.85M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-485612
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -15.21M 2013-01-01 2013-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-195076
us-gaap PartnersCapitalAccountRedemptions Partners' Capital Account, Redemptions USD 4.93M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap PaymentsForConstructionInProcess Payments for Construction in Process USD 146.37M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-485612
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD 2.99M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001564590-19-031304
us-gaap PaymentsForProceedsFromPreviousAcquisition Payments for (Proceeds from) Previous Acquisition USD 200.00M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 23.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 30.19M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006950
us-gaap PaymentsOfOrdinaryDividends Payments of Ordinary Dividends USD 55.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.79M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 371.50M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 71.02M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 50.00M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 138.44M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap PaymentsToAcquireRealEstate Payments to Acquire Real Estate USD 29.32M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue Pledged Assets Separately Reported, Other Assets Pledged as Collateral, at Fair Value USD 4.10M 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125623
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 188.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ProceedsFromCollectionOfLoansReceivable Proceeds from Collection of Loans Receivable USD 48.65M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 11.66M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 279.00M 2010-04-01 2010-04-30 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.05B 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -456,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromRentsReceived Proceeds from Rents Received USD 38.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 30.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromSaleAndCollectionOfLoansReceivable Proceeds from Sale and Collection of Loans Receivable USD 116.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ProceedsFromSaleOfLoansReceivable Proceeds from Sale of Loans Receivable USD 214.42M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125623
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 50.00M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 18.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromSaleOfRealEstate Proceeds from Sale of Real Estate USD 31.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProceedsFromSaleOfRealEstateHeldforinvestment Proceeds from Sale of Real Estate Held-for-investment USD 18.41M 2013-01-01 2013-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap ProceedsFromUnsecuredNotesPayable Proceeds from Unsecured Notes Payable USD 450.00M 2011-07-01 2011-07-31 2011 Q2 10-Q 2011-08-09 0001193125-11-214626
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 33.11M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProfitLossFromRealEstateOperations Profit (Loss) from Real Estate Operations USD 20.00M 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ProvisionForLoanAndLeaseLosses Provision for Loan and Lease Losses USD 20.35M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-12 0001193125-14-195076
us-gaap ProvisionForLoanLeaseAndOtherLosses Provision for Loan, Lease, and Other Losses USD 12.92M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023957
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 14.55M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap RealEstateAccumulatedDepreciation SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation USD 1.44B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAccumulatedDepreciationDepreciationExpense Real Estate Accumulated Depreciation, Depreciation Expense (Deprecated 2013-01-31) USD 31.03M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap RealEstateAccumulatedDepreciationOtherDeductions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Other Deduction USD 516,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap RealEstateAccumulatedDepreciationRealEstateSold SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold USD 74.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAndAccumulatedDepreciationAccumulatedDepreciation Real Estate and Accumulated Depreciation, Accumulated Depreciation (Deprecated 2013-01-31) USD 114.40M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap RealEstateAndAccumulatedDepreciationAmountOfEncumbrances SEC Schedule III, Real Estate and Accumulated Depreciation, Amount of Encumbrances USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount USD 9.02B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAndAccumulatedDepreciationCarryingAmountOfLand SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount USD 1.79B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAndAccumulatedDepreciationCarryingAmountOfLandAndBuildingsAndImprovements Real Estate and Accumulated Depreciation, Carrying Amount of Land and Buildings and Improvements (Deprecated 2013-01-31) USD 1.19B 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition, Cost USD 25.98M 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Cost Capitalized Subsequent to Acquisition, Improvements USD 20.91M 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements USD 8.59B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAndAccumulatedDepreciationInitialCostOfLand SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land USD 1.79B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateAssetsHeldForDevelopmentAndSale Real Estate Assets Held for Development and Sale USD 96.77M 2011-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap RealEstateCostOfRealEstateSold SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold USD 249.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateFederalIncomeTaxBasis SEC Schedule III, Real Estate, Federal Income Tax Basis USD 5.88B 2017-12-31 2017 FY 10-K 2018-03-01 0001193125-18-067584
us-gaap RealEstateGrossAtCarryingValue SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross USD 10.80B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateHeldForDevelopmentAndSale Real Estate Held for Development and Sale USD 40.46M 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap RealEstateHeldforsale Real Estate Held-for-sale USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateInvestmentPropertyAccumulatedDepreciation Real Estate Investment Property, Accumulated Depreciation USD 11.81M 2011-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures USD 1.39B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap RealEstateOtherAcquisitions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Acquisition USD 758.62M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap RealEstateOtherAdditions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Addition USD 96.78M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap RealEstateOtherDeductions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Deduction USD -819.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstateOwnedAccumulatedDepreciation Real Estate Owned, Accumulated Depreciation USD 1.44B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap RealEstatePeriodIncreaseDecrease SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Period Increase (Decrease) USD -219.67M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap ReceivablesFairValueDisclosure Receivables, Fair Value Disclosure USD 18.66M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ResidualValueOfLeasedAsset Residual Value of Leased Asset USD 110.00M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.95M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.16B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap Revenues Revenues USD 252.06M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 23.07M 2021-01-01 2021-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030989
us-gaap SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense USD 235.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap SecuredDebt Secured Debt USD 100.00M 2013-09-30 2013 Q3 10-Q 2013-11-08 0001193125-13-435134
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 2.80M 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 573,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 8.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005843
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0.085 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) pure 4 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.42 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.026 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 1.00M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 7.44M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.49M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 0 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080657
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 50,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 12.09 2007-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.36 2007-01-01 2007-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 7.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 1.00M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 10.95 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm1 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 1.8 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 110,000 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089355
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.001 2025-10-28 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap SignificantAcquisitionsAndDisposalsAcquisitionCostsOrSaleProceeds Significant Acquisitions and Disposals, Acquisition Costs or Sale Proceeds (Deprecated 2015-01-31) USD 621.49M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.54B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 4.55B 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 20,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.05B 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 23.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap StraightLineRent Straight Line Rent USD 49.50M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001564590-19-031304
us-gaap SubleaseIncome Sublease Income USD 4.30M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009901
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 41.27M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006950
us-gaap TreasuryStockValue Treasury Stock, Value USD 777,000 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008100
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 515,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-006950
us-gaap UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums USD 800,000 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 200,000 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap UndistributedEarningsAllocatedToParticipatingSecurities Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) USD 404,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-305062
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 2.96M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-02 0001193125-15-073689
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap UnsecuredDebt Unsecured Debt USD 450.00M 2011-04-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 8.50M 2012-12-31 2012 FY 10-K 2013-02-22 0001193125-13-071643
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.20M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-485612
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 2.34B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 602.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ValuationAllowancesAndReservesChargedToOtherAccounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account USD 7.34M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 426.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073587
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 800,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap ValuationAllowancesAndReservesRecoveries SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery USD 1.90M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023248
us-gaap ValuationAllowancesAndReservesReservesOfBusinessesAcquired SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired USD 14.50M 2020-01-08 2022 FY 10-K 2023-03-01 0000950170-23-005575
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 597.72M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 597.72M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214700
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 14.20M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-09 0001193125-11-304427

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →